![These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN.XIFAXAN® (rifaximin) tablets, for oral useInitial U.S. Approval: 2004To reduce the development These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN.XIFAXAN® (rifaximin) tablets, for oral useInitial U.S. Approval: 2004To reduce the development](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-05.jpg&id=663612)
These highlights do not include all the information needed to use XIFAXAN safely and effectively. See full prescribing information for XIFAXAN.XIFAXAN® (rifaximin) tablets, for oral useInitial U.S. Approval: 2004To reduce the development
Submissions received: Consultation Regulation Impact Statement: Options for reform of the regulatory framework for pharmacy comp
Attachment 1: Product information for AusPAR Xifaxan Rifaximin Norgine Pty Ltd 2011-00501-3-1 Final 19 November 2012
![Generic Xifaxan Rifaximin Tablet Exporter, Generic Xifaxan Rifaximin Tablet Supplier,Trader, Delhi,India Generic Xifaxan Rifaximin Tablet Exporter, Generic Xifaxan Rifaximin Tablet Supplier,Trader, Delhi,India](https://cpimg.tistatic.com/06606234/b/4/Generic-Xifaxan-Rifaximin-Tablet.jpg)
Generic Xifaxan Rifaximin Tablet Exporter, Generic Xifaxan Rifaximin Tablet Supplier,Trader, Delhi,India
![Salix Receives Anticipated FDA Complete Response Letter On XIFAXAN® 550 Mg Tablets Non-C IBS Supplemental New Drug Applica | Fierce Biotech Salix Receives Anticipated FDA Complete Response Letter On XIFAXAN® 550 Mg Tablets Non-C IBS Supplemental New Drug Applica | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Pills_Fahroni_GettyImages-1140100119.jpg?VersionId=qVhyOQ3grlnW2T0Ghs9rz3ujJyM2RUWx)